Immediate Impact
55 standout
Citing Papers
Advanced disease therapeutics using engineered living drug delivery systems
2025 Standout
Understanding the therapeutic toolkit for inflammatory bowel disease
2025 Standout
Works of Dilek Arikan being referenced
Open : Lymphoma Risk and Overall Safety Profile of Adalimumab in Patients With Crohn's Disease With up to 6 Years of Follow-up in the PYRAMID Registry
2018
P353 Long-term safety of adalimumab in patients with Crohn's disease: final data from PYRAMID registry
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Dilek Arikan | 96 | 90 | 138 | 92 | 25 | 404 | |
| Marissa J. Perman | 54 | 29 | 71 | 35 | 33 | 373 | |
| Nurit Vardinon | 157 | 25 | 118 | 81 | 14 | 384 | |
| Ana Strezova | 75 | 22 | 119 | 44 | 24 | 361 | |
| M G Ross | 30 | 35 | 61 | 45 | 12 | 417 | |
| Juan Sánchez‐Bursón | 221 | 23 | 152 | 37 | 24 | 393 | |
| Douglas P. Rhone | 52 | 24 | 37 | 39 | 25 | 428 | |
| Giancarlo Iaiani | 50 | 8 | 84 | 112 | 31 | 346 | |
| Srdjan Pasic | 34 | 26 | 124 | 100 | 23 | 403 | |
| F. Guibal | 67 | 14 | 33 | 56 | 26 | 370 | |
| Ángel Robles‐Marhuenda | 141 | 30 | 114 | 49 | 43 | 428 |
All Works
Loading papers...